| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |